WeightWatchers could either win big or lose faithful customers, or both, in its pivot to Ozempic trend

• In March, WeightWatchers announced it would acquire telemedicine startup Sequence.
• Sequence offers access to weight-loss drugs like Ozempic and Wegovy.
• Analysts say the move could save the company, but some WeightWatchers members aren't happy.

WeightWatchers is moving away from the group support meetings the company is known for, pivoting instead to using obesity medications for weight loss.